Squarepoint Ops LLC Obs Eva Sa Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.1 - $2.17 $12,577 - $24,811	-11,434 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.99 - $3.1 $22,753 - $35,445	11,434 New	11,434 $23,000
Q3 2020 Nov 16, 2020	SELL	$2.46 - $6.15 $58,806 - $147,015	-23,905 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.01 - $5.95 $48,049 - $142,234	23,905 New	23,905 $141,000
Q4 2019 Feb 14, 2020	SELL	$2.48 - $8.1 $32,619 - $106,539	-13,153 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.22 - $11.2 $2,079 - $2,833	253 Added 1.96%	13,153 $110,000
Q2 2019 Aug 14, 2019	BUY	$10.05 - $14.25 $129,645 - $183,825	12,900 New	12,900 $146,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.